Netherlands · Funded startup

Who invested in ProQR Therapeutics

2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 5 months ago

Funding summaryUpdated 26 Oct 2026

$68Mraised across 2 rounds since 2026, from 2 sources

$9.2MGrant$59MRound
Latest round
Round, $59MJun 2026
Step-upi
6.4×
Investors
2
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20262027
$9.2MGrant$59MRound
First round
Grant, $9.2M
Jan 2026
Biggest round
$59M
Round · Jun 2026
Between rounds
5 months
from the last two

The rounds

  1. Jun 2026
    Round$59M2 returning

    Source recorded

  2. Jan 2026
    Grant$9.2M2 new

    Source recorded

Founders and team

From ProQR Therapeutics's own website: 6 on the team.

  • Bart FiliusNon-Executive Director
  • Begoña Carreño PhDNon-Executive Director
  • Daniel A. de BoerExecutive Director
  • Gerard PlatenburgExecutive Director
  • Sarah KielyBoard of Directors
  • Theresa HeggieNon-Executive Director

AdvisersThomas Wolf

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Grant2026Round2026Sofinnova PartnersEli Lilly

Everyone who backed them

Sofinnova PartnersVC firm2rounds
Eli LillyCorporate VC2rounds

Missing a round, or an investor who was in one? Tell us.

Quick answers about ProQR Therapeutics

Who invested in ProQR Therapeutics?

ProQR Therapeutics's investors include Sofinnova Partners and Eli Lilly.

How much has ProQR Therapeutics raised?

ProQR Therapeutics has raised $68M across 2 rounds since 2026.

When did ProQR Therapeutics last raise?

ProQR Therapeutics's most recent round was an Undisclosed round of $59M in Jun 2026.

What was ProQR Therapeutics's biggest round?

Its most recent round, $59M in Jun 2026, is also its largest on record.

Who backed ProQR Therapeutics first?

ProQR Therapeutics's first round on record, in Jan 2026, was backed by Sofinnova Partners and Eli Lilly.

What stage is ProQR Therapeutics at?

ProQR Therapeutics's latest named round is an Undisclosed round, in Jun 2026.

Where is ProQR Therapeutics based?

ProQR Therapeutics is based in the Netherlands.

Companies like ProQR Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.